Office or other outpatient visit for the evaluation and management of an established patient that requires the supervision of a physician or other qualified health care professional and provision of up to 56 mg of esketamine nasal self-administration, includes 2 hours post-administration observation
Short Description: Visit esketamine 56m or less
Coverage Code: Carrier judgment
Action Code: Add procedure or modifier code
Date Added: January 1, 2020
Effective Date: January 1, 2020
Termination Date: